Open original FDA record ↗Recall record
- FDA identifier
- Z-1462-2008
- Company in FDA record
- Abbott Laboratories
- FDA classification date
- May 14, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Error Message: If the Positive and Negative Interpretation Cutoff parameters (116/117) are edited after installation of the revised assay file, VRTX error #0002 in Task 40 is generated and the instrument locks up when it attempts to report an AxSYM Amphetamine/Methamphetamine II patient result.
Source facts
- Action
- Consignees were sent a Product Correction-Immediate Action Required letter on 1/21/08. The letter provided users with the steps to take to temporarily correct the problem until the recalling firm is able to send a corrected assay file. Users were requested to return a customer reply letter acknowledging receipt of the letter. For additional information, contact 1-877-4ABBOTT.
- Initiated
- 2008-01-21
- Root cause
- Software change control
- Terminated
- 2009-12-01
- Distribution
- Worldwide Distribution including USA territory of Puerto Rico, and countries of Australia, Canada, Chile, Colombia, Germany, Mexico, New Zealand, South Korea, Taiwan, Thailand and Venezuela.
- Recall number
- Z-1462-2008
- Recall status
- Terminated
- CDRH record ID
- 68116
- FDA classified
- 2008-05-14
- Recall event number
- 46740